| Prevalence of prostate cancer among men with a prostate-specific antigen level≤ 4.0 ng per milliliter IM Thompson, DK Pauler, PJ Goodman, CM Tangen, MS Lucia, ... New England Journal of Medicine 350 (22), 2239-2246, 2004 | 3550 | 2004 |
| Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial IM Thompson, DP Ankerst, C Chi, PJ Goodman, CM Tangen, MS Lucia, ... Journal of the National Cancer Institute 98 (8), 529-534, 2006 | 1138 | 2006 |
| Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study D Fliser, B Kollerits, U Neyer, DP Ankerst, K Lhotta, A Lingenhel, E Ritz, ... Journal of the American Society of Nephrology 18 (9), 2600-2608, 2007 | 908 | 2007 |
| Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower IM Thompson, DP Ankerst, C Chi, MS Lucia, PJ Goodman, JJ Crowley, ... Jama 294 (1), 66-70, 2005 | 902 | 2005 |
| Chilling outweighs photoperiod in preventing precocious spring development J Laube, TH Sparks, N Estrella, J Höfler, DP Ankerst, A Menzel Global change biology 20 (1), 170-182, 2014 | 382 | 2014 |
| Effect of finasteride on the sensitivity of PSA for detecting prostate cancer IM Thompson, C Chi, DP Ankerst, PJ Goodman, CM Tangen, SM Lippman, ... Journal of the National Cancer Institute 98 (16), 1128-1133, 2006 | 373 | 2006 |
| Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16 DP Petrylak, DP Ankerst, CS Jiang, CM Tangen, MHA Hussain, ... Journal of the National Cancer Institute 98 (8), 516-521, 2006 | 328 | 2006 |
| Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis A Yildiz-Yesiloglu, DP Ankerst Psychiatry Research: Neuroimaging 147 (1), 1-25, 2006 | 302 | 2006 |
| Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy … A Yildiz-Yesiloglu, DP Ankerst Progress in Neuro-Psychopharmacology and Biological Psychiatry 30 (6), 969-995, 2006 | 266 | 2006 |
| Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low-vs high-grade prostate cancer DP Ankerst, J Hoefler, S Bock, PJ Goodman, A Vickers, J Hernandez, ... Urology 83 (6), 1362-1368, 2014 | 258 | 2014 |
| Interactions between temperature and drought in global and regional crop yield variability during 1961-2014 M Matiu, DP Ankerst, A Menzel PloS one 12 (5), e0178339, 2017 | 255 | 2017 |
| Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction CS Wilson, GS Davidson, SB Martin, E Andries, J Potter, R Harvey, K Ar, ... Blood 108 (2), 685-696, 2006 | 251 | 2006 |
| Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen A Yildiz, S Guleryuz, DP Ankerst, D Öngür, PF Renshaw Archives of general psychiatry 65 (3), 255-263, 2008 | 243 | 2008 |
| Handbook of statistics in clinical oncology J Crowley, A Hoering CRC Press, 2012 | 232 | 2012 |
| Validation of biomarker-based risk prediction models JMG Taylor, DP Ankerst, RR Andridge Clinical Cancer Research 14 (19), 5977-5983, 2008 | 219 | 2008 |
| Primary medical therapy of micro-and macroprolactinomas in men JJ Pinzone, L Katznelson, DC Danila, DK Pauler, CS Miller, A Klibanski The Journal of Clinical Endocrinology & Metabolism 85 (9), 3053-3057, 2000 | 197 | 2000 |
| The Schwarz criterion and related methods for normal linear models DK Pauler Biometrika 85 (1), 13-27, 1998 | 189 | 1998 |
| Prostate-specific antigen in the early detection of prostate cancer IM Thompson, DP Ankerst Cmaj 176 (13), 1853-1858, 2007 | 182 | 2007 |
| Obesity, adipokines, and prostate cancer in a prospective population-based study J Baillargeon, EA Platz, DP Rose, BH Pollock, DP Ankerst, S Haffner, ... Cancer Epidemiology Biomarkers & Prevention 15 (7), 1331-1335, 2006 | 177 | 2006 |
| Factors influencing serum CA125II levels in healthy postmenopausal women DK Pauler, U Menon, M McIntosh, HL Symecko, SJ Skates, IJ Jacobs Cancer Epidemiology Biomarkers & Prevention 10 (5), 489-493, 2001 | 176 | 2001 |
